Target intelligence / Profile preview

Vomeronasal receptor type 2 (V2R)

Target
V2R
Molecular classification
G protein-coupled receptor, Class C G protein-coupled receptor, Receptor
01

Overview

Vomeronasal receptor type 2 (V2R) is a family of G protein-coupled receptors (GPCRs) belonging to the Class C (metabotropic glutamate receptor-like) group. These receptors are primarily expressed in the basal layer of the vomeronasal organ (VNO), a specialized chemosensory structure in many vertebrates [6, 14]. V2Rs are distinguished by a large extracellular N-terminal domain that facilitates the sensing of non-volatile peptide and protein ligands, such as major histocompatibility complex (MHC) peptides and major urinary proteins (MUPs) [12, 14]. In rodents and other mammals, V2R signaling is mediated through the G-protein subunit Gαo, leading to the activation of phospholipase C and the opening of TRPC2 ion channels [1, 11]. These interactions are essential for mediating social recognition, mate selection, and reproductive behaviors in diverse animal species [5, 13]. In humans, however, the V2R gene family has undergone comprehensive pseudogenization, and the VNO itself is considered vestigial or non-functional in adults [6, 9]. Due to this evolutionary loss of function, Vomeronasal receptor type 2 is not currently utilized as a therapeutic target in clinical medicine, and there are no approved pharmacological agents developed to interact with this receptor family in a human context [12].

Other names
VMN2RVomeronasal type-2 receptorPheromone receptor V2RPheromone receptor type 2VNR2VN2
02

Mechanism of action

None

03

Biological functions

Signal transductionPheromone detectionSensory perception of chemical stimulusRegulation of social and reproductive behavior
04

Safety considerations

Lack of functional genes in humansVestigial nature of the vomeronasal organ in humansSpecies-specific ligand requirements

Beyond the preview

Go deeper on Vomeronasal receptor type 2 (V2R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vomeronasal receptor type 2 (V2R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call